Clinical Trial of Epsilon-Aminocaproic Acid in Severe Haemophilia

BMJ
doi 10.1136/bmj.1.5451.1632
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Differential Effects of Epsilon-Aminocaproic Acid and Aprotinin on Matrix Metalloproteinase Release in Patients Following Cardiopulmonary Bypass

Journal of Cardiovascular Pharmacology
Cardiovascular MedicinePharmacologyCardiology
2008English

Myocardial Infarction in Severe Haemophilia

The Journal of Haemophilia Practice
2018English

Inhibitor Development in Non-Severe Haemophilia Across Europe

Thrombosis and Haemostasis
Hematology
2015English

The Cost of Severe Haemophilia in Europe: The CHESS Study

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2017English

Transfusion Requirements of Adolescents With Severe Haemophilia A.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1979English

Factor XIa-triggered Thrombin Generation in Severe Haemophilia A

British Journal of Haematology
Hematology
2018English

Ynthesis and Properties of the Ε-Aminocaproic Acid Polyfluorinated Oligomers

Fluorine Notes
2016English

Combination of Aminocaproic Acid and Nicardipine in Treatment of Aneurysmal Subarachnoid Hemorrhage

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
1988English

Pharmacokinetics of Ε-Aminocaproic Acid in Neonates Undergoing Cardiac Surgery With Cardiopulmonary Bypass

Anesthesiology
AnesthesiologyPain Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy